Jha Reena C, Zanello Paulo A, Nguyen Xai Mai, Pehlivanova Marieta, Johnson Lynt B, Fishbein Thomas, Shetty Kirti
Department of Radiology, MedStar Georgetown University Hospital, 3800 Reservoir Rd, NW, Washington, DC 20007.
Clinica Zanello Diagnostico por Imagem, São Paulo, Brazil.
Acad Radiol. 2014 Nov;21(11):1455-64. doi: 10.1016/j.acra.2014.06.011.
Current clinical practice favors imaging rather than biopsy to diagnose hepatocellular carcinoma (HCC). There is a need to better understand tumor biology and aggressiveness of HCC. Our goal is to investigate magnetic resonance imaging (MRI) features of HCC that are associated with faster growth rates (GRs).
After approval from institutional review board, a retrospective evaluation was performed of pre-liver transplant patients. Fifty-two patients who developed a >2 cm HCC on serial imaging were included in the study group, with a total of 60 HCCs seen. Precursor foci were identified on serial MRIs before the specific diagnostic features of >2 cm HCC could be made, and GRs and MRI features, including signal on T1- and T2-weighted images (WI), the presence of intralesional steatosis on chemical shift imaging, and enhancement pattern were analyzed. GRs were correlated with imaging features.
The average GR of precursor lesions to >2 cm HCC was determined to be 0.23 cm/mo (standard deviation [SD], 0.32), with a doubling time of 5.26 months (SD, 5.44). The presence of increased signal intensity (SI) on T2-WI was associated with significantly higher growth (P = .0002), whereas increased intensity on T1-WI at the initial study was associated with a significantly lower GR (P = .0162). Furthermore, lesions with hypervascular enhancement with washout pattern had significantly higher GR (P = .0164). There is no evidence of differences in GRs seen in lesions with steatosis.
Small precursor lesions with increased SI on T2-WI and a washout pattern of enhancement are associated with faster GRs, which may suggest more aggressive tumor biology. These features may be helpful in patient management and surveillance for HCC.
当前临床实践中更倾向于采用影像学检查而非活检来诊断肝细胞癌(HCC)。有必要更好地了解HCC的肿瘤生物学特性和侵袭性。我们的目标是研究与更快生长速度(GRs)相关的HCC磁共振成像(MRI)特征。
经机构审查委员会批准后,对肝移植术前患者进行了回顾性评估。研究组纳入了52例在系列影像学检查中出现直径>2 cm HCC的患者,共观察到60个HCC。在能够确定直径>2 cm HCC的特定诊断特征之前,在系列MRI上识别出前驱病灶,并分析GRs和MRI特征,包括T1加权像(WI)和T2加权像上的信号、化学位移成像上瘤内脂肪变性的存在情况以及强化模式。将GRs与影像学特征进行关联分析。
前驱病灶至直径>2 cm HCC的平均GR为0.23 cm/月(标准差[SD],0.32),倍增时间为5.26个月(SD,5.44)。T2加权像上信号强度(SI)增加与显著更高的生长相关(P = .0002),而初始研究时T1加权像上强度增加与显著更低的GR相关(P = .0162)。此外,具有快进快出强化模式的病灶GR显著更高(P = .0164)。没有证据表明脂肪变性病灶的GRs存在差异。
T2加权像上SI增加且具有快进快出强化模式的小前驱病灶与更快的GRs相关,这可能提示肿瘤生物学行为更具侵袭性。这些特征可能有助于HCC患者的管理和监测。